Manufacturer:
Astellas
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Enrollment Forms:
Synergen Prescription Form
Approved Indication:
prophylaxis of organ rejection in adult and pediatric patients receiving allogenic liver, kidney, heart, or lung transplants, in combination with other immunosuppressants
Conditions:
- Solid Organ Transplant
Therapeutic Area:
- Cardiology
- Hepatology
- Nephrology
- Pulmonology
- Transplant